Crossmark

Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors

Crossref DOI link: https://doi.org/10.1007/s00280-015-2895-4

Published Online: 2015-11-03

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fujiwara, Yutaka

Nokihara, Hiroshi

Yamada, Yasuhide

Yamamoto, Noboru

Sunami, Kuniko

Utsumi, Hirofumi

Asou, Hiroya

TakahashI, Osamu

Ogasawara, Ken

Gueorguieva, Ivelina

Tamura, Tomohide
License Information

Text and Data Mining valid from 2015-11-03